Moshe Sarfaty
Vorstandsvorsitzender bei LS Biopath, Inc.
Aktive Positionen von Moshe Sarfaty
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LS Biopath, Inc.
LS Biopath, Inc. Medical SpecialtiesHealth Technology LS Biopath, Inc. provides a solution for real-time imaging of breast cancer surgical margins. The private company is based in Saratoga, CA. Breast-conserving-surgery is the most common treatment for breast tumors, and obtaining tumor-free surgical margins decreases the incidence of local recurrences. The company has developed Clearedge, an intra-operative imaging device that can effectively assess breast tissue margins during breast cancer surgery. The CEO of the company is Moshe Sarfaty. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | 01.01.2009 | - | |
Präsident | - | - | |
Aristagora VC Israel Management Ltd. | Private Equity Investor | 01.07.2020 | - |
Karriereverlauf von Moshe Sarfaty
Ehemalige bekannte Positionen von Moshe Sarfaty
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Krypton Venture Capital Ltd.
Krypton Venture Capital Ltd. Investment ManagersFinance Krypton Venture Capital Ltd. (Krypton Venture Capital) is a venture capital firm founded in 2014 by Moshe Sarfaty. The firm is headquartered in Bnei Brak, Israel. | Gründer | 01.01.2013 | 02.07.2020 |
Ausbildung von Moshe Sarfaty
Yale University | Undergraduate Degree |
Statistik
International
Israel | 3 |
Vereinigte Staaten | 3 |
Operativ
Founder | 1 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sektoral
Finance | 3 |
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Krypton Venture Capital Ltd.
Krypton Venture Capital Ltd. Investment ManagersFinance Krypton Venture Capital Ltd. (Krypton Venture Capital) is a venture capital firm founded in 2014 by Moshe Sarfaty. The firm is headquartered in Bnei Brak, Israel. | Finance |
LS Biopath, Inc.
LS Biopath, Inc. Medical SpecialtiesHealth Technology LS Biopath, Inc. provides a solution for real-time imaging of breast cancer surgical margins. The private company is based in Saratoga, CA. Breast-conserving-surgery is the most common treatment for breast tumors, and obtaining tumor-free surgical margins decreases the incidence of local recurrences. The company has developed Clearedge, an intra-operative imaging device that can effectively assess breast tissue margins during breast cancer surgery. The CEO of the company is Moshe Sarfaty. | Health Technology |
Aristagora VC Israel Management Ltd. | Finance |
- Börse
- Insiders
- Moshe Sarfaty
- Erfahrung